Dorothy Engelking serves as Executive at Neos Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Dorothy Engelking has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 1, 2018 involved receiving (via award) 3,750 shares valued at $0.
Dorothy Engelking currently holds 10,416 shares of Neos Therapeutics, Inc. (NEOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dorothy Engelking has been a net neutral trader of NEOS stock. They have purchased $0 and sold $0 worth of shares.
Dorothy Engelking's most recent insider trade was on Mar 1, 2018, when they sold 3,750 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 28, 2015 | NEOS | $0 | Conversion | 416 | $N/A | Discretionary |